Abstract:Background: Hyperhomocysteinemia (HHcy) is an established risk factor for atherothrombogenic diseases. In this study we investigated the effect of HHcy on EC-platelets interaction and its role in thrombosis. Methods and Results: We used a novel mouse model of HHcy (plasma homocysteine, Hcy 80 μ M) in which a Zn 2+ inducible human cystathionine β -synthase ( C BS ) transgene was introduced to circumvent the neonatal lethality of Cbs deficiency ( Tg-hCBS Cbs −/− mice). Hcy-lowering therapy was performed by giving ZnSO 4 water to induce human CBS transgene expression in adult mice. Thrombus formation was examined by photo-dye induced cremaster microvasculature thrombosis using intra-vital microscope, which preserved the endothelium, and by FeCl 3 -induced carotid artery thrombosis, which denudated the endothelium. HHcy accelerated cremaster arteriolar thrombosis and decreased blood flow cessation time from 41.8 min in control mice to 30.5 min in Tg-hCBS Cbs −/− mice. Venular blood flow cessation time was slightly decreased from 5.6 to 5.0 min. Hcy-lowering therapy reduced Hcy level from 80 μ M to 2 μ M after 2 weeks of ZnSO 4 water and prolonged arteriolar blood cessation time from 30.5 to 37.8 min. Interestingly, FeCl 3 -induced carotid artery thrombosis did not change. Hcy did not potentiate aggregation and secretion of washed human platelets from healthy donor treated with Hcy (50, 100 μ M) and from Tg-hCBS Cbs −/− mice. However, ICAM-1 levels, but not VCAM-1, were increased in cremaster tissues from Tg-hCBS Cbs −/− mice by western blot. In cultured human umbilical vein ECs (HUVEC), Hcy (100 μ M, 24h) promoted human platelet adhesion by 200% in static adhesion assay. Using western blot, FACS and RT-PCR, we found that Hcy increased protein and mRNA levels of ICAM-1, but not that of VCAM-1, in HUVEC. ICAM-1 blocking antibody partially reversed Hcy-increased platelets adhesion to HUVEC. Finally, Hcy induced ICAM-1 expression and reduced DNA methylation on ICAM-1 promoter, which were mimicked by DNA methyltransferase inhibitor azacytidine, and histone deacetylase inhibitors sodium butyrate and trichostatin A. Conclusion: HHcy accelerates arteriolar thrombosis and increases EC-platelets interaction via ICAM-1 induction partially through promoter hypomethylation.

Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells

Homocysteine Stimulates Nuclear Factor Κb Activity and Interleukin-6 Expression in Rat Vascular Smooth Muscle Cells

Effects of Homocysteine on the Expression of Matrix Metalloproteinase-2 in Rat Vascular Smooth Muscle Cells

Effect of homocysteine on expression of interleukin-6 and NF-kappa B activity in cultured rat vascular smooth muscle cells

Effect of Homocysteine on Expression of Intercellular Adhesion Molecule-2 and Adhesion of Dendritic Cells to Cultured Human Umbilical Vein Endothelial Cells

Effect of Homocysteine on Secretion and Expression of Interleukin-6 in Cultured Rat Vascular Smooth Muscle Cells

Aberrant Dna Methylation of the Pdgf Gene in Homocysteine-Mediated Vsmc Proliferation and Its Underlying Mechanism

Homocysteine-mediated Expression of SAHH, DNMTs, MBD2, and DNA Hypomethylation Potential Pathogenic Mechanism in VSMCs.

Homocysteine induces connective tissue growth factor expression in vascular smooth muscle cells.

Abstract 14623: ICAM-1 Mediates Hyperhomocysteinemia Accelerated Arteriolar Thrombosis and Endothelial -Platelets Interaction

Homocysteine Upregulates Soluble Epoxide Hydrolase in Vascular Endothelium in Vitro and in Vivo

Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial Cells

Impaired Autophagy Mediates Hyperhomocysteinemia-Induced HA-VSMC Phenotypic Switching

The mechanism of proliferation of vascular smooth muscle induced by hyperhomocysteinemia

Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis.

Global DNA methylation and extracellular matrix remodeling in aortic smooth muscle versus endothelial cells in hyperhomocysteinemia (1120.5)

Hyperhomocysteinemia-mediated DNA Hypomethylation and Its Potential Epigenetic Role in Rats.

Homocysteine Impaired Endothelial Function Through Compromised Vascular Endothelial Growth Factor/Akt/Endothelial Nitric Oxide Synthase Signalling

Hyperhomocysteinemia Promotes Inflammatory Monocyte Generation and Accelerates Atherosclerosis in Transgenic Cystathionine Beta-Synthase-Deficient Mice

Homocysteine potentiates calcification of cultured rat aortic smooth muscle cells.

Proteomic analysis of homocysteine induced proliferation of cultured neonatal rat vascular smooth muscle cells